Adalimumab induced psoriasis during the treatment of inflammatory bowel disease – case report

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease – case report

Introduction. Anti-tumor necrosis factor α (anti-TNF-α) antibodies are used to treat immune-mediated inflammatory diseases (IMID), which include inflammatory bowel diseases or psoriasis. In the group of adverse events induced by anti-TNF agents we can observe psoriatic lesions. Case report . We...

Full description

Bibliographic Details
Main Authors: Edyta Lelonek, Magdalena Dębicka, Joanna Maj, Anita Hryncewicz-Gwóźdź, Łukasz Matusiak
Format: Article
Language:English
Published: Termedia Publishing House 2015-09-01
Series:Przegląd Dermatologiczny
Subjects:
psoriasis
anti-TNF agents
adalimumab
Crohn’s disease
Online Access:http://www.termedia.pl/Adalimumab-induced-psoriasis-during-the-treatment-of-inflammatory-bowel-disease-case-report,56,25611,1,1.html

Internet

http://www.termedia.pl/Adalimumab-induced-psoriasis-during-the-treatment-of-inflammatory-bowel-disease-case-report,56,25611,1,1.html

Similar Items